Surgery Partners, Inc.
SGRY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,747 | $2,823 | $3,007 | $2,672 |
| - Cash | $203 | $250 | $229 | $270 |
| + Debt | $369 | $3,879 | $3,863 | $3,703 |
| Enterprise Value | $2,913 | $6,451 | $6,641 | $6,106 |
| Revenue | $822 | $826 | $776 | $864 |
| % Growth | -0.6% | 6.5% | -10.2% | – |
| Gross Profit | $195 | $196 | $162 | $234 |
| % Margin | 23.8% | 23.7% | 20.9% | 27% |
| EBITDA | $405 | $152 | $98 | $161 |
| % Margin | 49.3% | 18.4% | 12.7% | 18.6% |
| Net Income | -$23 | -$3 | -$38 | -$109 |
| % Margin | -2.8% | -0.3% | -4.9% | -12.6% |
| EPS Diluted | -0.18 | -0.02 | -0.3 | -0.86 |
| % Growth | -813.7% | 93.4% | 65.1% | – |
| Operating Cash Flow | $84 | $81 | $6 | $111 |
| Capital Expenditures | -$20 | -$23 | -$23 | -$22 |
| Free Cash Flow | $64 | $58 | -$17 | $89 |